Helus Pharma shareholders approve name change to take effect October 1, 2026

Sep 22, 2026 21:00 (32d ago)

Verifying

Helus Pharma shareholders approved changing the company’s legal name to Helus Pharma Inc.
46,452,598 shares represented 63.58% of outstanding shares at the September 22 meeting.
Helus Pharma elected eight director nominees and appointed Zeifmans LLP as auditor.

The information on this website is generated using AI and we cannot guarantee its accuracy. Please use it as reference information only.